Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01884662 · ClinicalTrials.gov registry record · NA
Virtual Walking for Neuropathic Pain in Spinal Cord Injury
A NA study of Spinal Cord Injury and Neuropathic Pain, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT01884662: Completed NA study of Spinal Cord Injury and Neuropathic Pain, sponsored by University of Alabama at Birmingham.
NCT01884662 is a NA study of Spinal Cord Injury and Neuropathic Pain that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 67 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01884662, a NA study of Spinal Cord Injury and Neuropathic Pain, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
Spinal cord injury neuropathic pain (SCI-NP) is a common problem, and when severe, is one of the most problematic of secondary conditions that is minimally to modestly responsive to currently available treatments. It is usually described as burning or stabbing, and is located at or below the level at which their sensation changes from normal to impaired; persons with no feeling at all in their legs for example can experience pain in the legs. The purpose of this project is to further investigate the use of a novel visual stimulation treatment; a technique that has shown benefit in other populations with chronic pain secondary to deafferentation. To accomplish this, a novel treatment - virtual reality (VR) walking - will be examined. Should this treatment show benefit, a portable, accessible means of treatment will be available for persons with SCI and for whom transportation to health care providers is often difficult.
Primary Outcome
The NRS is the most commonly used pain rating scale, and ranges from 0/10 to 10/10 with 10 representing unbearable or the "worst possible pain".
Conditions Studied
Interventions
- BEHAVIORAL Virtual walking
- BEHAVIORAL Wheeling tape
Study Locations (1)
Alabama
- Spain REhabilitation Center - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2012-09 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT01884662 record still lists
NCT01884662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (22% lower).
The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Virtual walking is the first listed.
NCT01884662 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT01884662 about?
NCT01884662 is a clinical study titled "Virtual Walking for Neuropathic Pain in Spinal Cord Injury". Spinal cord injury neuropathic pain (SCI-NP) is a common problem, and when severe, is one of the most problematic of secondary conditions that is minimally to modestly responsive to currently available treatments. It is usually described as burning or stabbing, and is located at or below the level a...
What is the current status of trial NCT01884662?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2012-09. Estimated completion is 2021-06-30.
What conditions does trial NCT01884662 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Neuropathic Pain.
What interventions are being tested in trial NCT01884662?
The interventions under investigation include: Virtual walking (BEHAVIORAL), Wheeling tape (BEHAVIORAL).
Who is sponsoring clinical trial NCT01884662?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01884662 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01884662's enrollment target sits among peer trials
67 29th of 99 higher than 71 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia